Log In
  • Home
  • About
    • About DCAT
    • Our History
    • Governance Structure
    • Board of Directors
    • Program Management Council
    • Committees & Task Forces
    • Staff
    • Past Presidents
    • Antitrust & Ethics Policies
    • Volunteer Engagement Opportunities
    • Scholarship Initiatives
  • Membership
    • Our Members
    • Member Directory
    • Become a Member
    • Renew Membership
    • Member Resources
  • Events
    • Upcoming Events
    • Future DCAT Week Dates
    • DCAT Sharp Sourcing
    • DCAT Women's Virtual Networking Breakfast
    • Alliance for Industry Women Webinar Series
    • Women Leaders in Pharma Interview Series
    • Scholarship Golf Outing
    • Code of Conduct Policy
  • DCAT Connect
    • About DCAT Connect
    • Go to DCAT Connect
  • Contact
    • Contact Information
    • Media Center
    • Logo Use and License
Stay connected, subscribe to our newsletter.
Subscribe
  • Event Schedule
  • DCAT Week
  • DCAT Sharp Sourcing
  • DCAT Women's Virtual Networking Breakfast
  • DCAT Alliance for Industry Women Webinars
  • Women Leaders in Pharma Interview Series
  • DCAT Scholarship Golf Outing
  • Future DCAT Week Dates

speaker bios

Laurie J. Chipperfield

Laurie J. Chipperfield is Senior Director, Global External Supply, Pfizer Worldwide Research & Development. She joined Pfizer Inc. in 1989 and has held positions of increasing leadership in the areas of operations, supply chain, regulatory, and strategic sourcing. She is currently Senior Director, Global External Supply, responsible for all externally sourced active pharmaceutical ingredients (APIs) and API intermediates manufactured for the company’s clinical portfolio. Prior to her current role, she had roles at Pfizer locations in Groton Connecticut, New York, New York, and Puerto Rico and also supported Pfizer’s commercial manufacturing sites in Europe.

She received a Bachelor of Science degree in chemical engineering from Northeastern University and an MBA from Rensselaer Polytechnic Institute.

Andrew D. Skibo

Andrew D. Skibo is Chief Manufacturing Officer, FluGen, a vaccine-development company, and former Head of Global Biologics Operations for AstraZeneca, from which he retired in 2019 and now serves an advisory/consultancy role to the company.  He has over 40 years of experience in the pharmaceutical industry, with a career focused on manufacturing operations, quality, process development, and capital project development.  Prior to retiring in April 2019, Mr. Skibo served for eleven years as MedImmune’s Executive Vice President of Operations and Astra Zeneca’s Head of Global Biologics Operations. The latter role included responsibilities for AstraZeneca’s biologics and vaccine franchises. He has related experience with both operating companies (Amgen, Roche’s Genentech, and Monsanto [now part of Bayer]) and large international engineering and construction firms specializing in the biopharmaceutical/pharmaceutical industry (Foster Wheeler, Life Sciences International, and Fluor). 

He has served as Chairman of the International Society for Pharmaceutical Engineering (ISPE) and Chairman of the Global Pharmaceutical Manufacturers Leadership Forum. He holds a Bachelor’s of Science degree in chemistry and a Master’s of Science degree in chemical engineering, both from the Massachusetts Institute of Technology.  

Chad P Bown, PhD

Chad P. Bown, PhD, is Senior Fellow, the Peterson Institute for International Economics (PIIE), where his research examines international trade laws and institutions, trade negotiations, and trade disputes. Prior to joining PIIE in 2018, Dr. Bown previously served as Senior Economist for International Trade and Investment in the White House on the Council of Economic Advisers, and most recently, as a lead economist at the World Bank, where he conducted research and advised developing country governments on international trade policy for seven years. Dr. Bown was a tenured professor of economics at Brandeis University, where he held a joint appointment in the Department of Economics and International Business School for 12 years. He has also spent a year in residence as a visiting scholar in economic research at the World Trade Organization (WTO) Secretariat in Geneva. Dr. Bown is also currently a research fellow at the Centre for Economic Policy Research in London and a member of the Council on Foreign Relations.  

Since 2011 he has co-directed, with Petros C. Mavroidis of Columbia Law School, an annual program of scholars providing legal-economic assessments of WTO case law and jurisprudence that are published with Cambridge University Press. He currently serves on the editorial boards of a number of journals, including Economics & Politics, International Economics, Journal of International Economics, Journal of International Economic Law, Journal of International Trade Law and Policy, Journal of World Trade, Review of International Organizations, and World Trade Review. 

In addition, his work has been published in journals such as American Economic Review, Journal of Economic Literature, Review of Economics and Statistics, Journal of International Economics, and Journal of Development Economics. He is the author of Self-Enforcing Trade: Developing Countries and WTO Dispute Settlement and co-editor, The Law, Economics, and Politics of Retaliation in WTO Dispute Settlement. His volume on the global economic crisis, The Great Recession and Import Protection: The Role of Temporary Trade Barriers, was built from a trade policy transparency project that he initiated at the World Bank in 2004. The project resulted in the Global Antidumping Database, which he managed through 2016 as part of the World Bank's Temporary Trade Barriers Database.  

Jim Miller (Moderator)

Jim Miller is Content Advisor/Consultant to the Drug, Chemical & Associated Technologies Association (DCAT). He is a preeminent expert in bio/pharmaceutical outsourcing and industry consultant with than 20 years of experience in the bio/pharmaceutical industry. He is the founder and former President of PharmSource, a provider of market intelligence on bio/pharmaceutical contract manufacturing and development, which GlobalData acquired in 2016. Prior to founding PharmSource in 1996, Mr. Miller was formerly Vice President of Sales and Marketing at Circa Pharmaceuticals, Inc., a solid-dose manufacturer. Prior to that, he was President of St. Anthony Publishing, a provider of database information services for the healthcare industry. He also was a consultant in corporate strategy with the Boston Consulting Group. He holds an MBA degree from the Stanford University Graduate School of Business.

Drug, Chemical & Associated
Technologies Association (DCAT)
Global Headquarters
One Union St., Suite 207
Robbinsville, NJ 08691
Phone: +1-609-208-1888
Toll free: +1-800-640-DCAT (3228)
International: +41 61 510 05 00
Fax: +1-609-208-0599
info@dcat.org

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting biopharmaceutical/pharmaceutical development and manufacturing.

© 2021 DCAT | Privacy Policy | Terms Of Use | Cookies & Ads Policy | Your California Privacy Rights

✖
Our Sites use cookies and similar technologies for essential site purposes to allow you to use our site and to allow us to provide essential site-related services to you. Find out more about how we use cookies by visiting our Privacy Policy. By continuing to use our site, you acknowledge our cookies policy.